Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print August 26, 2008
DOI: 10.2337/db08-0830

This Article
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Wentzel, P.
Right arrow Articles by Eriksson, U. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wentzel, P.
Right arrow Articles by Eriksson, U. J.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Decreased cardiac glutathione peroxidase levels and enhanced mandibular apoptosis in malformed embryos of diabetic rats

Parri Wentzel1, Mattias Gäreskog1, and Ulf J. Eriksson1

1Department of Medical Cell Biology, Uppsala University, SE-75123 Uppsala, Sweden

Objective: To characterize normal and malformed embryos within the same litters from control and diabetic rats for expression of genes related to metabolism of reactive oxygen species (ROS) or glucose, and developmental genes.

Research design and methods: Embryos from non-diabetic and streptozotocin-diabetic rats were collected on gestational day 11 and evaluated for gene expression (PCR) and distribution of activated Caspase-3 and glutathione peroxidase-1 (Gpx-1) by immunohistochemistry.

Results: Maternal diabetes (MD) caused growth retardation and increased malformation rate in the embryos compared to controls (N). We found decreased gene expression of Gpx-1 and increased expression of Vascular endothelial growth factor-A (Vegf-A) in malformed embryos of diabetic rats (MDm), compared with non-malformed littermates (MDn). Alterations of mRNA levels of other genes were similar in MDm and MDn embryos. Thus, expression of Copper Zinc superoxide dismutase (CuZnSOD), Manganese superoxide dismutase (MnSOD), and Sonic hedgehog homolog (Shh) were decreased, and Bone morphogenetic protein-4 (Bmp-4) was increased in the MD embryos compared to N embryos. In MDm embryos, we detected increased activated Caspase-3 immunostaining in the first visceral arch and cardiac area, and decreased Gpx-1 immunostaining in the cardiac tissue, both findings differed from the Caspase/Gpx-1 immunostaining of the MDn and N embryos.

Conclusions: Maternal diabetes causes growth retardation, congenital malformations and decreased general antioxidative gene expression in the embryo. In particular, enhanced apoptosis of the first visceral arch and heart, together with decreased cardiac Gpx-1 levels may compromise the mandible and heart to an increased risk of developing congenital malformation.


Correspondence: parri.wentzel{at}mcb.uu.se


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.